FormWeb • nivolumab

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

Nivolumab

nivolumab

Restricted Opdivo --> Restricted to Outpatient Medical.
Restricted Anti-Neoplastic Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Opdivo	SOLUTION, INTRAVENOUS	10 mg/mL

VIEW MORE Antineoplastic Agents
CLASS

Comments:

Opdivo medication guide

Opdivo -- Indicated for resistant cases of melanoma and NSCLC, given IV every 2 weeks. Defer to outpatient setting if possible. Rare inpatient use expected.

For Updated Formulary Preferred Products (Inpatient and Outpatient): Preferred Products for Select Agents

Reviewed: 25 August 2015 (Opdivo)

Last updated: Apr. 11, 2024

Chemotherapy:

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.